首頁 > 市場調查報告書 > 製藥

處方藥

市場調查報告書

商品編碼

1812435

碘海醇注射市場按應用、劑型、強度、給藥途徑、最終用戶和地區分類

Iohexol Injection Market, By Application, By Dosage Forms, By Strength, By Route of Administration, By End User, By Geography

出版日期: 2025年08月01日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

碘海醇注射市場規模預計在 2025 年為 17.1 億美元，預計到 2032 年將達到 30.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 8.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	17.1億美元
效能數據	2020年至2024年	預測期	2020年至2024年
預測期：2025-2032年複合年成長率：	8.50%	2032年的價值預測	30.3億美元

全球碘海醇注射市場是藥物顯影劑產業的重要組成部分，主要貢獻於全球醫療保健系統的診斷影像。碘海醇是一種非離子型水溶性顯影劑，已成為各種醫學影像程序（包括電腦斷層掃描 (CT)、血管造影術和造影）的重要組成部分。與離子型顯影劑相比，這種低莫耳顯影劑具有更高的安全性，在診斷過程中可減少副作用並提高患者耐受性。

市場上涵蓋各種規格和包裝形式的碘海醇注射液，旨在滿足各種診斷成像應用的多樣化臨床需求。由於其卓越的造影性能、快速的清除機制以及與現代成像技術的兼容性，醫療保健提供者越來越信賴碘海醇注射液。需要診斷影像的慢性疾病的增多，加上新興國家醫療基礎設施的進步，正在推動市場擴張。此外，微創診斷方法的普及以及易患心血管和神經系統疾病的老年人口的不斷成長，也對市場成長做出了重要貢獻。製藥業致力於開發安全性更高、副作用更少的改良劑型，這使得碘海醇注射成為現代診斷醫學的重要工具，並進一步推動了這個專業治療領域的創新。

市場動態

全球碘海醇注射劑市場在一個複雜的生態系統中運作，這個生態系統由市場促進因素、限制因素和機會組成，這些因素共同決定了市場的發展軌跡。關鍵的市場促進因素包括全球日益加重的心血管疾病、癌症和神經系統疾病負擔，這些疾病需要先進的診斷影像，增加了對可靠顯影劑的需求。新興市場醫療基礎設施的快速擴張，加上醫療成本的上升和政府促進早期疾病檢測的舉措，極大地推動了市場的成長。診斷影像設備的技術進步需要相容的顯影劑，加上對門診診斷程序的日益成長的偏好，進一步推動了市場擴張。然而，市場面臨重大限制，包括管理顯影劑核准流程的嚴格法律規範、與顯影劑相關的潛在副作用以及新製劑的高研發成本。

此外，無需造影顯影劑的替代影像技術的可用性以及脆弱患者群體中顯影劑劑誘發腎臟病的風險構成了重大挑戰。供應鏈中斷和原料價格波動也會影響市場穩定。然而，透過開發安全性更高的下一代顯影劑、擴展到服務不足的地區市場以及製藥公司和醫療保健提供者之間的策略聯盟，龐大的商機正在湧現。人工智慧在診斷影像領域的日益普及為增強顯影劑的使用創造了機會，而新興國家醫療旅遊業的擴張也帶來了新的市場潛力。此外，對個人化醫療和精準診斷的日益關注為針對特定患者群體和臨床狀況量身定做的碘海醇製劑鋪平了道路。

本次調查的主要特點

本報告對全球碘海醇注射市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，概述了全球碘海醇注射市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、最新策略、市場擴張和行銷策略做出明智的決策。
全球碘海醇注射劑市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球碘海醇注射劑市場的各種策略矩陣，相關人員將更容易做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.71 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.50%	2032 Value Projection:	USD 3.03 Bn

The Global Iohexol Injection Market represents a critical segment within the pharmaceutical contrast media industry, primarily serving diagnostic imaging procedures across healthcare systems worldwide. Iohexol, a non-ionic, water-soluble contrast agent, has established itself as an essential component in various medical imaging modalities including computed tomography (CT), angiography, and urography procedures. This low-osmolar contrast medium demonstrates superior safety profiles compared to ionic alternatives, exhibiting reduced adverse reactions and enhanced patient tolerance during diagnostic examinations.

The market encompasses various concentration formulations and packaging formats designed to meet diverse clinical requirements across different imaging applications. Healthcare providers increasingly rely on Iohexol injections due to their excellent contrast enhancement properties, rapid clearance mechanisms, and compatibility with modern imaging technologies. The growing prevalence of chronic diseases requiring diagnostic imaging, coupled with advancing healthcare infrastructure in emerging economies, continues to drive market expansion. Additionally, the increasing adoption of minimally invasive diagnostic procedures and the rising geriatric population susceptible to cardiovascular and neurological conditions contribute significantly to market growth. The pharmaceutical industry's focus on developing improved formulations with enhanced safety profiles and reduced side effects further propels innovation within this specialized therapeutic segment, positioning Iohexol injections as indispensable tools in contemporary diagnostic medicine.

Market Dynamics

The Global Iohexol Injection Market operates within a complex ecosystem of drivers, restraints, and opportunities that collectively shape its trajectory. Primary market drivers include the escalating global burden of cardiovascular diseases, cancer, and neurological disorders necessitating advanced diagnostic imaging procedures, thereby increasing demand for reliable contrast agents. The rapid expansion of healthcare infrastructure in developing nations, coupled with increasing healthcare expenditure and government initiatives promoting early disease detection, significantly propels market growth. Technological advancements in imaging equipment requiring compatible contrast media, along with the growing preference for outpatient diagnostic procedures, further stimulate market expansion. However, the market faces considerable restraints including stringent regulatory frameworks governing contrast agent approval processes, potential adverse reactions associated with contrast media administration, and the high costs of research and development for new formulations.

Additionally, the availability of alternative imaging techniques that don't require contrast agents and the risk of contrast-induced nephropathy in vulnerable patient populations pose significant challenges. Supply chain disruptions and raw material price volatility also impact market stability. Nevertheless, substantial opportunities emerge through the development of next-generation contrast agents with improved safety profiles, expansion into underserved geographic markets, and strategic partnerships between pharmaceutical companies and healthcare providers. The increasing adoption of artificial intelligence in diagnostic imaging creates opportunities for enhanced contrast agent utilization, while growing medical tourism in emerging economies presents new market avenues. Furthermore, the rising focus on personalized medicine and precision diagnostics opens pathways for specialized Iohexol formulations tailored to specific patient demographics and clinical conditions.

Key Features of the Study

This report provides in-depth analysis of the global Iohexol injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Iohexol Injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GE HealthCare, Torso Healthcare, MANUS AKTTEVA BIOPHARMA LLP, Farbe Firma, Swasthya Healthcare Pvt. Ltd., Intelicure Lifescience, Onko Ilac Sanayi ve Ticaret A.S, Grupo Juste, and Jiangsu Hengrui Medicine
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Iohexol injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Iohexol injection market

Market Segmentation

Application Insights (Revenue, USD Bn, 2020 - 2032)
- Computed Tomography (CT) Scans (Body/organ imaging)
- Angiography and Angiocardiography
- Myelography
- Arthrography
- Other Applications (e.g., Urography, Hysterosalpingography, ERCP)
Dosage Forms Insights (Revenue, USD Bn, 2020 - 2032)
- Injection
- Oral Solution
Strength Insights (Revenue, USD Bn, 2020 - 2032)
- 140 mg iodine/mL
- 180 mg iodine/mL
- 240 mg iodine/mL
- 300 mg iodine/mL
- 350 mg iodine/mL
- 9 mg iodine/mL
- 12 mg iodine/mL
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intrathecal
- Intra-arterial
- Intravenous
- Oral
- Rectal
- Intraarticular
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adults
- Pediatric
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals and Specialty Clinics
- Diagnostic Centers
- Imaging Centers
- Ambulatory Surgical Centers
- Others (Research and Academic Institutes)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GE HealthCare
- Torso Healthcare
- MANUS AKTTEVA BIOPHARMA LLP
- Farbe Firma
- Swasthya Healthcare Pvt. Ltd.
- Intelicure Lifescience
- Onko Ilac Sanayi ve Ticaret A.S
- Grupo Juste
- Jiangsu Hengrui Medicine

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Iohexol Injection Market, By Application
- Global Iohexol Injection Market, By Dosage Forms
- Global Iohexol Injection Market, By Strength
- Global Iohexol Injection Market, By Route of Administration
- Global Iohexol Injection Market, By Age Group
- Global Iohexol Injection Market, By End User
- Global Iohexol Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Iohexol Injection Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Computed Tomography (CT) Scans (Body/organ imaging)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Angiography and Angiocardiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Myelography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Arthrography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Applications (e.g., Urography, Hysterosalpingography, ERCP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Iohexol Injection Market, By Dosage Forms, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Iohexol Injection Market, By Strength, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
140 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
180 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
240 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
300 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
350 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12 mg iodine/mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Iohexol Injection Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intra-arterial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intraarticular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Iohexol Injection Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Iohexol Injection Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Research and Academic Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Iohexol Injection Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Forms, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Torso Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MANUS AKTTEVA BIOPHARMA LLP
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Farbe Firma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Swasthya Healthcare Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Intelicure Lifescience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Onko Ilac Sanayi ve Ticaret A.S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Grupo Juste
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jiangsu Hengrui Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

碘海醇注射市場按應用、劑型、強度、給藥途徑、最終用戶和地區分類

Iohexol Injection Market, By Application, By Dosage Forms, By Strength, By Route of Administration, By End User, By Geography

市場動態

目錄

第 1 章：調查目標與先決條件

第2章市場展望

第3章：市場動態、法規與趨勢分析

4. 2020 年至 2032 年全球碘海醇注射劑市場（依應用）

5. 2020-2032 年全球碘海醇注射市場（按劑型）

6. 2020 年至 2032 年全球碘海醇注射劑市場規模

7. 2020-2032 年全球碘海醇注射市場（依給藥途徑）

8. 2020-2032 年全球碘海醇注射市場（依年齡層分類）

9. 2020-2032 年全球碘海醇注射劑市場（依最終用戶分類）

第 10 章。 2020-2032 年按地區分列的全球碘海醇注射市場

第11章競爭格局

第 12 章分析師建議

第13章參考文獻與調查方法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Iohexol Injection Market, By Application, 2020-2032, (USD Bn)

5. Global Iohexol Injection Market, By Dosage Forms, 2020-2032, (USD Bn)

6. Global Iohexol Injection Market, By Strength, 2020-2032, (USD Bn)

7. Global Iohexol Injection Market, By Route of Administration, 2020-2032, (USD Bn)

8. Global Iohexol Injection Market, By Age Group, 2020-2032, (USD Bn)

9. Global Iohexol Injection Market, By End User, 2020-2032, (USD Bn)

10. Global Iohexol Injection Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

碘海醇注射市場按應用、劑型、強度、給藥途徑、最終用戶和地區分類

Iohexol Injection Market, By Application, By Dosage Forms, By Strength, By Route of Administration, By End User, By Geography

市場動態

目錄

第 1 章：調查目標與先決條件

第2章 市場展望

第3章：市場動態、法規與趨勢分析

4. 2020 年至 2032 年全球碘海醇注射劑市場（依應用）

5. 2020-2032 年全球碘海醇注射市場（按劑型）

6. 2020 年至 2032 年全球碘海醇注射劑市場規模

7. 2020-2032 年全球碘海醇注射市場（依給藥途徑）

8. 2020-2032 年全球碘海醇注射市場（依年齡層分類）

9. 2020-2032 年全球碘海醇注射劑市場（依最終用戶分類）

第 10 章。 2020-2032 年按地區分列的全球碘海醇注射市場

第11章 競爭格局

第 12 章分析師建議

第13章參考文獻與調查方法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Iohexol Injection Market, By Application, 2020-2032, (USD Bn)

5. Global Iohexol Injection Market, By Dosage Forms, 2020-2032, (USD Bn)

6. Global Iohexol Injection Market, By Strength, 2020-2032, (USD Bn)

7. Global Iohexol Injection Market, By Route of Administration, 2020-2032, (USD Bn)

8. Global Iohexol Injection Market, By Age Group, 2020-2032, (USD Bn)

9. Global Iohexol Injection Market, By End User, 2020-2032, (USD Bn)

10. Global Iohexol Injection Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

第2章市場展望

第11章競爭格局